John Fuller
Impact in
- Endocrinology, Diabetes and Metabolism top 0.05%
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Diabetes Management and Research
- Diabetes Treatment and Management
- Nephrology top 0.2%
- Chronic Kidney Disease and Diabetes
Papers in
-
- Diabetes, Cardiovascular Risks, and Lipoproteins 66
- Diabetes Management and Research 57
- Diabetes Treatment and Management 8
- Nephrology 34
- Chronic Kidney Disease and Diabetes 34
- Co-authors
- Nishi Chaturvedi (95 shared papers)Helen Martina Colhoun (37 shared papers)HARRY KEEN (29 shared papers)Lynda K. Stevens (29 shared papers)Judith Stephenson (17 shared papers)G. A. Hitman (19 shared papers)Paul N. Durrington (19 shared papers)D. J. Betteridge (18 shared papers)
- Journals
- Diabetologia (52 papers)Diabetes Care (33 papers)Diabetic Medicine (24 papers)The Lancet (14 papers)Diabetes (6 papers)
- Partner nations
- United KingdomNetherlandsItaly
In The Last Decade
John Fuller
233 papers receiving 19.5k citations
John Fuller's Hit Papers
Peers
Comparison fields: 5 of 148
- Endocrinology, Diabetes and Metabolism 7.5k
- Nephrology 2.3k
- Ophthalmology 2k
- Cardiology and Cardiovascular Medicine 3k
- Clinical Biochemistry 492
Countries citing papers authored by John Fuller
This map shows the geographic impact of John Fuller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Fuller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Fuller more than expected).
Fields of papers citing papers by John Fuller
This network shows the impact of papers produced by John Fuller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Fuller. The network helps show where John Fuller may publish in the future.
Co-authors
The 25 scholars most cited alongside John Fuller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 234 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial Hit paper breakdown → | 2004 | 2998 |
| 2 | Vascular Risk Factors and Diabetic Neuropathy Hit paper breakdown → | 2005 | 1078 |
| 3 | Mortality and causes of death in the WHO multinational study of vascular disease in diabetes Hit paper breakdown → | 2001 | 1010 |
| 4 | Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials Hit paper breakdown → | 2019 | 607 |
| 5 | Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes Hit paper breakdown → | 1998 | 604 |
| 6 | Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study Hit paper breakdown → | 1996 | 555 |
| 7 | Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Hit paper breakdown → | 1983 | 529 |
| 8 | Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials Hit paper breakdown → | 2008 | 369 |
| 9 | Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial Hit paper breakdown → | 2008 | 361 |
| 10 | 1983 | 345 | |
| 11 | 2006 | 328 | |
| 12 | 1994 | 292 | |
| 13 | 2005 | 242 | |
| 14 | 1979 | 241 | |
| 15 | 2001 | 238 | |
| 16 | 2009 | 211 | |
| 17 | 2004 | 209 | |
| 18 | 2008 | 195 | |
| 19 | 2003 | 191 | |
| 20 | 2009 | 189 |
About John Fuller
John Fuller is a scholar working on Endocrinology, Diabetes and Metabolism, Nephrology, Cardiology and Cardiovascular Medicine, Ophthalmology and Surgery, having authored 234 papers that have together received 21.2k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (66 papers), Diabetes Management and Research (57 papers), Chronic Kidney Disease and Diabetes (34 papers), Lipoproteins and Cardiovascular Health (31 papers), Retinal Diseases and Treatments (17 papers), Blood Pressure and Hypertension Studies (14 papers), Nutritional Studies and Diet (8 papers) and Diabetes Treatment and Management (8 papers). The work is most often cited by research in Endocrinology, Diabetes and Metabolism (7.5k citations), Nephrology (2.3k citations), Ophthalmology (2k citations), Cardiology and Cardiovascular Medicine (3k citations) and Clinical Biochemistry (492 citations). John Fuller has collaborated with scholars based in United Kingdom, Netherlands and Italy. Frequent co-authors include Nishi Chaturvedi, Helen Martina Colhoun, HARRY KEEN, Lynda K. Stevens, Judith Stephenson, G. A. Hitman, Paul N. Durrington, D. J. Betteridge, H. A. W. Neil and Shona J. Livingstone. Their work appears in journals such as Diabetologia, Diabetes Care, Diabetic Medicine, The Lancet and Diabetes.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.